My research focuses on the economics and political economy of science and technology, primarily in the life sciences. My current projects examine: (1) The effects of the globalization of drug patent protection on innovation, prices, and access to medicines; (2) The impact of the World War II research effort on the rate and direction of postwar science and innovation, and on the scientists involved; (3) The role of the government in pharmaceutical innovation, and implications for public policy; and (4) The economics of crisis innovation and crisis innovation policy. My previous work includes research on the political economy of the the NIH, the economic impact of public science, patent data as economic indicators, the economics of the patent system, pharmaceutical and life science patent policy, and university entrepreneurship/technology transfer.
PhD, 2001, Columbia University
M Phil, 2000, Columbia University
MA, 1998, Columbia University
BA, 1996, Columbia University
Research Associate, National Bureau of Economic Research
Affiliated Faculty, Columbia Law School
Steering Committee, NBER Innovation Information Initiative
Steering Committee, Columbia University Precision Medicine and Society Program
Honors & Awards
Areas of Expertise
Gross, Dan, and Bhaven N. Sampat. "The Economics of Crisis Innovation: A Historical Perspective." American Economic Review Papers and Proceedings. (Forthcoming, 2021).
Sampat, Bhaven N. "Whose Drugs Are These?" Issues in Science and Technology (2020).
Sampat, Bhaven N., and Heidi L. Williams. "How do patents affect follow-on innovation? Evidence from the human genome." American Economic Review 109 (2019): 203-36.
Azoulay, Pierre, Graff-Zivin, Joshua, Li, Danielle, and Bhaven N. Sampat "Public R&D investments and private-sector patenting: evidence from NIH funding rules." The Review of Economic Studies 86 (2019): 117-152.
Li, Danielle, Pierre Azoulay, and Bhaven N. Sampat. "The applied value of public investments in biomedical research." Science (2017): 78-81.
Hegde, Deepak, and Bhaven Sampat. "Can private money buy public science? Disease group lobbying and federal funding for biomedical research." Management Science 61.10 (2015): 2281-2298.
Hemphill, C. Scott, and Bhaven N. Sampat. "Evergreening, patent challenges, and effective market life in pharmaceuticals." Journal of health economics 31.2 (2012): 327-339.
Sampat, Bhaven N., and Frank R. Lichtenberg. "What are the respective roles of the public and private sectors in pharmaceutical innovation?." Health Affairs 30.2 (2011): 332-339.